Navigation Links
Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
Date:8/12/2013

SAN DIEGO, Aug. 12, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today reported on a research collaboration with researchers at Boston Children's Hospital, to assess the medical utility of Excellagen® as a delivery scaffold to seed autologous mesenchymal fetal stem cells for ex-vivo engineering of tissue grafts for transplantation into infants to repair prenatally diagnosed birth defects. 

(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

Autologous mesenchymal fetal stem cells are derived prenatally from infants with a medical defect requiring life-saving tissue repairs.  These stem cells are sourced from amniotic fluid, the placenta or umbilical cord blood.  The stem cells are then seeded into a scaffold to promote the growth of an engineered tissue graft.  These grafts will potentially be used to surgically repair, either in the fetus or immediately following birth, certain prenatally diagnosed birth defects that could include congenital diaphragmatic hernia, tracheal and chest wall defects, bladder extrophy and various cardiac anomalies.  Preliminary pre-clinical research has confirmed that Excellagen collagen homogenate maintains mesenchymal fetal stem cell viability.  Additional proof of concept studies are currently underway.

"Boston Children's team has made remarkable progress in the field of tissue regeneration and surgical repair of prenatally diagnosed congenital defects.  We believe that Excellagen has an opportunity serve as a delivery platform in the field of stem cell therapy and we look forward to continuing to work with the Boston Children's team to help make their innovative therapeutic vision a new standard of care, and potentially advance stem cell therapies toward commercialization," stated Christopher J. Reinhard, Chairm
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties
2. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
3. Cardium Completes Preferred Stock Financing
4. Cardium Announces Reverse Stock Split
5. Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
6. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
7. Cardium Announces Generx Publication In Molecular Therapy
8. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
9. Cardium Presents Year-End 2012 Financial Results And Recent Developments
10. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
11. Cardium Receives ISO Certification for Excellagen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 Amgen (NASDAQ: AMGN ) today ... on Tuesday, July 29, 2014, after the close of the ... conference call with the investment community at 2 p.m. PT. ... A. Bradway , chairman and chief executive officer, and other ... of the conference call will be simultaneously broadcast over the ...
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... "the company") announced today that the company,s board of directors ... 31 to June 30. Accordingly, DelMar will file a Transition ... Jeffrey Bacha , president and CEO of DelMar stated, ... in achieving our goal of obtaining a senior exchange listing ...
(Date:7/24/2014)...  Perrigo Company (NYSE: PRGO ; TASE) ... equivalent rating from the U.S. Food and Drug Administration ... for testosterone gel 1.0%. FDA concluded that Perrigo,s testosterone ... can be substituted with the full expectation that it ... as AndroGel 1% when used under the conditions specified ...
Breaking Medicine Technology:Amgen Announces Webcast of 2014 Second Quarter Financial Results 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3
... YORK, Dec. 7, 2011 Reportlinker.com announces ... available in its catalogue: ... Japan http://www.reportlinker.com/p0702529/Future-Therapeutic-Drug-Monitoring-Market-US-Europe-Japan.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... TDM market will undergo significant transformation. These ...
... Talyst announces AutoPharm® Mobile, an Apple iOS application ... can be conveniently accessed on an Apple iOS ... across the health system. AutoPharm ... access to medication inventory throughout the health system. ...
Cached Medicine Technology:Future Therapeutic Drug Monitoring Market: US, Europe, Japan 2Future Therapeutic Drug Monitoring Market: US, Europe, Japan 3Future Therapeutic Drug Monitoring Market: US, Europe, Japan 4Future Therapeutic Drug Monitoring Market: US, Europe, Japan 5Future Therapeutic Drug Monitoring Market: US, Europe, Japan 6Future Therapeutic Drug Monitoring Market: US, Europe, Japan 7Future Therapeutic Drug Monitoring Market: US, Europe, Japan 8Future Therapeutic Drug Monitoring Market: US, Europe, Japan 9Talyst Releases AutoPharm Mobile 2
(Date:7/25/2014)... Hills, CA (PRWEB) July 25, 2014 Agoura ... a special promotion on Zoom Whitening. Zoom Whitening is one ... is only available through a dental professional. This light-assisted treatment ... into the structure of the tooth to break up stains ... is effective on coffee, tea, wine, soft drink and tobacco ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The rising pharmaceutical ... leading to the growth of the US PBM industry. A ... and value of pharmaceutical sales in the US over the ... be attributed to rise in the prescription volume over the ... Pharmacy Benefit Management (PBM): 2013 Edition” the demand for the ...
(Date:7/25/2014)... July 25, 2014 Ross A. Clevens, ... been invited to join the exclusive Obagi Clinical Advisory ... facial plastic surgeons, plastic surgeons and dermatologists. , ... exclusive Advisory Board of thought leaders held its first ... meeting was to give Obagi the opportunity to meet ...
(Date:7/25/2014)... (HealthDay News) -- Dietary changes can dramatically alter the ... basis, according to a new study. These ... detect and ease flare-ups for people with certain chronic ... Crohn,s disease), the researchers said. Trillions of bacteria ... human health isn,t well understood, the Massachusetts Institute of ...
(Date:7/25/2014)... July 25, 2014 ZeptoMetrix™ Corporation ... reliable and trusted products and services for infectious ... release of NATtrol™ RP Multimarker Controls - ... in vitro diagnostic, CE marked, unassayed external run ... assays the NATtrol™ RP Multimarker Controls - MDZ001 ...
Breaking Medicine News(10 mins):Health News:Agoura Hills Dentist, Dr. Amir Choroomi, is Now Offering a Promotion on Zoom Whitening 2Health News:US Pharmacy Benefit Management (PBM) Market Trends and Developments Now Available at MarketReportsOnline.com 2Health News:US Pharmacy Benefit Management (PBM) Market Trends and Developments Now Available at MarketReportsOnline.com 3Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2Health News:Diet Changes Can Alter Gut Bacteria, Study Says 2Health News:ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls 2
... , WEDNESDAY, Sept. 14 (HealthDay News) -- ... new research suggests that people who kick the habit ... from the University of Missouri found that smoking is ... (often being emotionally negative and anxious) among adults under ...
... Alexandria, Va., USA - The International and American ... proceedings from the 3rd AADR Fall Focused Symposium ... symposium was held November 12-13, 2010, in Washington, ... Symposium under the objective to provide networking opportunities ...
... Division of Pain Medicine in the Department of ... Neurological Institute have each received 2011 Medical & ... Institutions for these nationally competitive awards are reviewed ... comprised of leaders in the field. The ...
... likely than Caucasians to be not only diagnosed with head and ... answer isn,t a simple one, differences in lifestyle, access to care ... a new study from Henry Ford Hospital. The study also ... current smokers, one of the primary risk factors for head and ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- For ... on staff, "telestroke" may be a cost-effective option to ... say. Telestroke, or virtual stroke care, ... through two-way audio-video equipment. "In an era of ...
... The human papillomavirus (HPV) is more likely to be ... and those with private health insurance, according to a new ... also reveals that laryngeal cancer patients with Medicare, who tend ... HPV, suggesting that HPV infection may be closely tied to ...
Cached Medicine News:Health News:Quitting Smoking May Improve Personality, Study Suggests 2Health News:IADR/AADR publish proceedings from the AADR Fall Focused Symposium on Salivary Diagnostics 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 3Health News:Rural Stroke Victims May Benefit From 'Virtual' Care 2Health News:Gender, insurance type tied to HPV infection in laryngeal cancer patients 2Health News:Gender, insurance type tied to HPV infection in laryngeal cancer patients 3
Inquire...
Inquire...
... and simplicity at the point of care: , ... volume of only 70 L of whole blood (all ... after change of sensor cassette , safePICO mixer ensures ... a sample in 7 seconds) * ...
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie...
Medicine Products: